| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8770370 | Journal of Renal Nutrition | 2017 | 9 Pages |
Abstract
Treatment with PA21 was effective in lowering and maintaining target serum phosphorus concentrations in Japanese hemodialysis patients with hyperphosphatemia over 52Â weeks. PA21 was generally well tolerated in the long term.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Fumihiko MD, PhD, Keitaro MD, PhD, Masafumi MD, PhD, Tadao MD, PhD,